The accelerating pace of U.S. FDA approvals for cell and gene therapies is “great for the field and great news for the patients,” but questions remain over commercialization, with “costs remaining ...

Americans Skip Overseas Travel as Stem Cell Exosome Therapy Lands at 5 U.S. Locations New York, United States - May 14, ...

Regenerative medicine has become a major field of medical practice over the past few decades. But for most, these non-invasive and holistic treatments have remained inaccessible. Now, that’s starting ...

Japan's regenerative medicine market offers opportunities driven by an aging population, progressive regulations, and demand for novel therapies targeting chronic and cosmetic conditions. Innovations ...

Despite challenges for approval and access, regenerative therapies for retinal diseases may not be far away from becoming ...

It’s a well-known and almost quaint fact that the human body is capable of regeneration. When we suffer a minor scrape or a ...

Ultrasome™ Demonstrates Strong Clinical Signal While Leveraging GMP-Produced CELZ-201 (Olastrocel) to Target Large, Underserved Osteoarthritis Market PHOENIX, April 28, 2026 (GLOBE NEWSWIRE) -- ...

From stem cells to platelet-rich plasma, regenerative medicine is often positioned as the future of healthcare. But not all approaches deliver on that promise. As interest grows, so do questions ...

The Australia regenerative medicine market offers significant opportunities in cellular therapies, tissue engineering, and aesthetic applications, driven by aging populations and chronic disease ...